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Previously we have characterized 3-ketosteroid 9-hydroxylase (KSH), a key enzyme in microbial steroid
degradation in Rhodococcus erythropolis strain SQ1, as a two-component iron-sulfur monooxygenase, comprised
of the terminal oxygenase component KshA1 and the oxygenase-reductase component KshB. Deletion of the
kshA1 gene resulted in the loss of the ability of mutant strain RG2 to grow on the steroid substrate 4-andro-
stene-3,17-dione (AD). Here we report characteristics of a close KshA1 homologue, KshA2 of strain SQ1,
sharing 60% identity at the amino acid level. Expression of the kshA2 gene in mutant strain RG2 restored
growth on AD and ADD, indicating that kshA2 also encodes KSH activity. The functional complementation was
shown to be dependent on the presence of kshB. Transcriptional analysis showed that expression of kshA2 is
induced in parent strain R. erythropolis SQ1 in the presence of AD. However, promoter activity studies, using
-lactamase of Escherichia coli as a convenient transcription reporter protein for Rhodococcus, revealed that the
kshA2 promoter in fact is highly induced in the presence of 9-hydroxy-4-androstene-3,17-dione (9OHAD) or
a metabolite thereof. Inactivation of kshA2 in parent strain SQ1 by unmarked gene deletion did not affect
growth on 9OHAD, cholesterol, or cholic acid. We speculate that KshA2 plays a role in preventing accumu-
lation of toxic intracellular concentrations of ADD during steroid catabolism. A third kshA homologue was
additionally identified in a kshA1 kshA2 double gene deletion mutant strain of R. erythropolis SQ1. The
developed degenerate PCR primers for kshAmay be useful for isolation of kshA homologues from other (actino)
bacteria.
Rhodococcus species display a wide range of metabolic ca-
pabilities, degrading a variety of environmental pollutants and
transforming or synthesizing compounds with possible useful
applications (3, 26, 30). A well-known feature of rhodococci is
their ability to degrade a range of naturally occurring steroids,
including cholesterol and phytosterols, e.g., -sitosterol (26).
3-Ketosteroid 9-hydroxylase (KSH) is a key enzymatic
step in the microbial steroid catabolic pathway, acting on 4-
androstene-3,17-dione (AD) or 1,4-androstadiene-3,17-dione
(ADD) (Fig. 1). Introduction of the 9-hydroxyl moiety into
the steroid polyheterocyclic ring structure, combined with ste-
roid 1-dehydrogenation by 3-ketosteroid 1-dehydrogenase
(KSTD), initiates steroid B-ring opening due to the formation
of chemically unstable 9-hydroxy-1,4-androstadiene-3,17-
dione (9OHADD) (Fig. 1). KSH of Rhodococcus erythropolis
SQ1 is a two-component class IA monooxygenase comprised of
the terminal oxygenase KshA1 and the oxygenase reductase
component KshB (23). Classification of nonheme oxygenases is
based on the number of constituent components and the na-
ture of their redox centers (2, 6, 8–10, 13). By definition, class
I oxygenases are two-component enzymes composed of a re-
ductase component and a terminal oxygenase component. The
reductase component of oxygenases contains either a flavin
mononucleotide (class IA) or a flavin adenine dinucleotide
(class IB), an NAD binding domain, and a [2Fe-2S] redox
center situated either N terminally (class IB) or C terminally
(class IA).
In previous work we have shown that gene inactivation of
either kshA1 (mutant strain RG2) or kshB (mutant strain
RG4) in parent strain R. erythropolis SQ1 results in loss of
3-ketosteroid 9-hydroxylation activity (24). Consequently,
these mutants were unable to grow on both AD and ADD as
sole carbon and energy sources. Such KSH mutant strains have
industrial applications and can be used for the selective 1-
dehydrogenation of pharmaceutically important steroids by
biotransformation (28). Interestingly, growth of strain RG2 on
cholesterol was comparable to that of parent strain SQ1. Bio-
transformation of cholesterol by cultures of strain RG2 did not
result in accumulation of the expected steroid pathway inter-
mediates (i.e., AD and ADD), indicative of the presence of at
least one additional degradation pathway. By contrast, the
inactivation of a single kshA gene by transposon mutagenesis in
Mycobacterium smegmatis mc2155 was recently shown to cause
accumulation of AD and ADD from -sitosterol (1). We thus
anticipated the presence of additional gene homologues of
kshA in R. erythropolis. Recent studies have shown that rhodo-
cocci often contain multiple homologues of catabolic genes,
thereby drastically improving their catabolic capabilities (26).
The Rhodococcus jostii RHA1 genome sequence revealed the
presence of up to four distinct pathways for steroid catabolism,
each containing a kshA gene homologue (11, 27).
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Currently, there is only very limited knowledge about KSH
enzymes/genes, hampering industrial applications in the field
of microbial steroid biotransformation. Studies of KSH en-
zymes furthermore are of medical importance. A gene cluster
encoding the cholesterol catabolic pathway in R. jostii RHA1
was recently shown to be linked to the pathogenicity of Myco-
bacterium tuberculosis (27). M. tuberculosis is the causative
agent of tuberculosis, causing millions of deaths every year.
Notably, genes encoding enzymes involved in steroid ring
opening, i.e., KSH, encoded by Rv3526, and KSTD, encoded
by Rv3537, were identified as important for M. tuberculosis
survival in macrophages (5, 17). The medical and applied as-
pects of KSH enzymes make them interesting enzymes to study
in more detail.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Rhodococcus erythropolis parent
strain SQ1 (16) and mutant strains were cultivated at 30°C and 200 rpm. Mutant
strains RG2 (kshA1 mutant), RG4 (kshB mutant), and RG9 (kshA1 kstD kstD2
mutant) were previously described (24). Complex rich medium (LBP) contained
1% (wt/vol) Bacto peptone (Difco), 0.5% (wt/vol) yeast extract (BBL Becton
Dickinson and Company), and 1% (wt/vol) NaCl (21). Mineral medium (pH 7)
consisted of 4.65 g/liter K2HPO4, 1.5 g/liter NaH2PO4  H2O, 3 g/liter NH4Cl, 1
g/liter MgSO4  7H2O, and 1 ml/liter of fivefold-diluted Vishniac trace element
solution (29). Cholesterol (1 g/liter) and cholic acid (1 g/liter) were added prior
to autoclaving. Other steroids (0.5 g/liter) were solubilized in dimethyl sulfoxide
(DMSO; 50 mg/ml) and added to autoclaved medium. The sucrose sensitivities
of Rhodococcus strains were tested on LBP agar supplemented with 10% (wt/vol)
sucrose. Escherichia coli strains were grown in Luria-Bertani (LB) broth at 37°C.
Bacto agar (1.5% [wt/vol]; Difco) was added for growth on solid media.
PCR screening of genomic library using degenerate primers. PCR was per-
formed in a reaction mixture (50 l) consisting of Tris-HCl (10 mM, pH 8)
buffer, polymerase buffer, deoxynucleoside triphosphate (0.2 mM), DMSO (2%),
KshAType-F primer (10 ng/l), KshAType-R primer (10 ng/l), and Taq or Vent
polymerase (2 U) under the following conditions: 5 min at 95°C and 30 cycles of
1 min at 95°C, 45 s at 60°C, and 1 min at 72°C, followed by 5 min at 72°C. The
previously described genomic library of R. erythropolis RG1, a kstD mutant of
parent strain SQ1, was used as template (24).
RNA isolation and RT-PCR experiments. Rhodococcus cultures were grown in
LBP medium (250 ml) until an optical density at 600 nm of approximately 2 was
reached. When appropriate, cultures were induced for 4 h with steroids (0.5
g/liter) dissolved in DMSO. Following centrifugation (10 min, 7,300  g, 4°C),
the cell pellet was crushed by pestle and mortar in liquid N2 and stored at 80°C
until use. Total RNA was subsequently isolated using the RNeasy isolation kit
(Qiagen). Prior to reverse transcriptase-PCR (RT-PCR), the isolated total RNA
was treated with a DNase I amplification-grade kit (Invitrogen, The Nether-
lands) for 15 min at room temperature. DNase I was heat inactivated for 10 min
at 65°C. RT-PCR was performed with approximately 0.5 g total RNA, deter-
mined on a GeneQuant spectrophotometer, using the SuperScript III Platinum
One Step GRT-PCR system kit (Invitrogen, The Netherlands). All kits were used
according to the manufacturer’s recommendations. cDNA made by the reverse
transcriptase reaction (15 min at 50°C) was heated for 2 min at 95°C and used for
PCR (40 cycles of 30 s at 95°C, 30 s at 60°C, and 1.5 min at 72°C). Gene-specific
primers used for the RT-PCR experiments are listed in Table 1.
Construction of mutagenic plasmid pKSH310 for kshA2 unmarked gene de-
letion. Gene deletion of kshA2 was achieved with pKSH310. A 1.2-kb SalI
fragment of pAR1 (this study; see Results), representing the upstream region of
FIG. 1. Schematic representation of the key enzyme steps involved in the degradation of the steroid intermediates AD, ADD, 9OHAD, and
[9OHADD] during steroid ring degradation in R. erythropolis strain SQ1. KSTD1 and KSTD2 represent KSTDs in SQ1 (25). KshA1, KshA2, and
KshB represent two multicomponent KSHs of SQ1 (24; this study). KSR represents 3-ketosteroid 1-reductase activity (see text). Thick arrows
represent the proposed preferred route of steroid B-ring opening, aimed at keeping intracellular ADD concentrations low.
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kshA2, was cloned into XhoI-digested pBluescript (II) KS and named pKSH307.
The PCR product (2.2 kb), obtained with primers KSHA2-F and delKSHA2-R
(Table 1) using strain SQ1 genomic DNA, was cloned into EcoRV-digested
pZeRO-2.1 vector (Invitrogen), yielding pKSH308. A 1-kb SalI/SpeI fragment of
pKSH308, containing the downstream region of kshA2, was subsequently ligated
into SalI/SpeI-digested pKSH307, thereby producing pKSH309. The two ligated
fragments, harboring the kshA2 deletion, were then taken from pKSH309 by
Asp718I/XbaI digestion, treated with Klenow enzyme, and cloned into SmaI-
digested pK18mobsacB vector (18), thereby producing pKSH310 (Fig. 2).
Construction of unmarked gene deletion mutants RG23, RG24, and RG27.
Gene deletion mutants were constructed using the unmarked gene deletion
method as described previously (23). The mutagenic plasmid pKSH310 was
introduced into R. erythropolis SQ1 and RG2 by bacterial conjugation using E.
coli S17-1 (19) to construct kshA2 mutant strain RG23 and kshA1 kshA2 mutant
strain RG24. Mutagenic plasmid pKSH126 (23) was introduced into R. eryth-
ropolis RG4 to construct a kshA1 kshB mutant strain, RG27. Gene deletions were
confirmed by PCR using gene-specific primers (Table 1).
Functional complementation experiments and construction of plasmids used.
Electrocompetent Rhodococcus cells were prepared and transformed as previ-
ously described (22). Rhodococcus transformants were replica plated onto min-
eral agar medium containing AD or ADD (0.5 g/liter) as sole carbon and energy
source. Functional complementation for growth was scored after 3 days of
incubation at 30°C. Plasmids pKSH312 and pKSH313 (Fig. 3), used for func-
tional complementation experiments, were constructed as follows. The kshA2
gene was amplified by PCR using kshA2 primers KSHA2EX-F and KSHA2EX-R
(Table 1) and subsequently cloned as an NdeI/SpeI fragment into NdeI/SpeI-
digested pRESX (Fig. 3), resulting in plasmid pKSH312 (Fig. 3). Plasmid
pKSH313, for simultaneous expression of kshA2 and kshB, was constructed by
ligating a 1.46-kb NsiI/SpeI fragment of pKSH207 (24) containing kshB into
NsiI/SpeI-digested pKSH312.
Bioconversion experiments and analysis by gas chromatography and high-
pressure liquid chromatography. Steroid biotransformations and steroid analysis
were performed (in duplicate) in shaking flasks containing 100-ml LBP-grown
cultures of R. erythropolis strains essentially as previously described (22).
kshA2 promoter activity study and -lactamase assay. A leaderless bla gene
(20) was amplified from pBluescript (II) KS by PCR using oligonucleotides BLF
and BLR (Table 1). The obtained PCR product was digested with NdeI/SpeI and
cloned into NdeI/SpeI-digested pRESX (Fig. 3). The leaderless bla gene, includ-
ing rhodococcal ribosomal binding site sequence, was subsequently isolated from
pRESX-BLAS following BstXI/SpeI digestion. The BstXI site was made blunt by
T4 DNA polymerase treatment prior to SpeI digestion. The resulting DNA
fragment was cloned under the control of the kshA2 promoter into EcoRV/SpeI-
TABLE 1. PCR oligonucleotides used in this study
Primer Specificity Amplicon size Nucleotide sequence (5–3)a
KshAType-F kshA homologue 0.3 kb TGYCCITTCCAYGAYTGGCGITGGGGIGG
KshAType-R kshA homologue TGIACGTAAAGAAGRTGIGCCATRTC
KshA2-F kshA2, kshA3 0.6 kb CTCGATGCCTACTGCCGTCAC
KshA2-R kshA2, kshA3 CGGATAGTGGCAGTTGATCAAAAC
KSHA2EX-F kshA2 1,167 bp GGCCATATGTTGACCACAGACGTGACGACC (NdeI)
KSHA2EX-R GCCACTAGTTCACTGCGCTGCTCCTGCACG (SpeI)
RT-KSHA2-F kshA2 469 bp AGCCAGAGCGAATTGAAGGT
RT-KSHA2-R ATGTCGTCGCGGTTGATACC
RT-KSTD1-F kstD1 489 bp CCAGGTGCAGGAACGCGCCG
RT-KSTD1-R CGCCTTGATTCGCTGGGTTT
16SRNA-RHODO-F 16S rRNA 427 bp GTCTAATACCGGATATGACCTC
16SRNA-RHODO-R R. erythropolis (4) GCAAGCNAGNAGTTGAGCTGCTGGT
delKSHA2-R Upstream kshA2 NAb TCGAATACTGGGGACACGAAGC
BLF bla 809 bp GCGCATATGCACCCAGAAACGCTGGTGAAAG (NdeI)
BLR GCGACTAGTTACCAATGCTTAATCAGTGAGGC (SpeI)
a I, inosine; Y, CT; R, AG; N, any base. Underlined nucleotide sequences indicate incorporated restriction sites.
b NA, not applicable.
FIG. 2. Scheme of the genomic locus of kshA2 of R. erythropolis SQ1 and the cloning strategy to construct mutagenic plasmid pKSH310 used
for unmarked kshA2 gene deletion in kshA1 mutant strain R. erythropolis RG2. Upstream of kshA2, another open reading frame (ORF2) is found
encoding a protein with signatures of IclR-type transcriptional regulators.
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digested pKSH307, encompassing the 1.2-kb genomic SalI fragment (Fig. 2).
Finally, the kshA2 promoter and truncated bla gene were cloned into pRESQ,
resulting in pRESQ307BLAS used for the kshA2 promoter activity measure-
ment. Rhodococcus cells harboring pRESQ307BLAS were grown in 100 ml
glucose (20 mM) mineral medium supplemented with kanamycin (200 g/ml)
until the optical density at 600 nm reached 1.5 to 2.5. Induction (5 h) was
performed using steroids at a final concentration of 0.25 g/liter where appropri-
ate. -Lactamase activity was measured at 37°C in 100 mM potassium phosphate
buffer, pH 7.0, using 0.5 mg/ml nitrocefin (ε486 	 15.6  103 M1  cm1) (14).
Nucleotide sequence accession numbers. The R. erythropolis SQ1 sequence
data for kshA2, ORF2, and kshA3 have been submitted to the DDBJ/EMBL/
GenBank databases under accession numbers EU656136 (kshA2 and ORF2) and
FJ040874 (kshA3).
RESULTS
Designing degenerate PCR primers for identification of ad-
ditional kshA homologues in kshA1 mutant Rhodococcus eryth-
ropolis strain RG2. Degenerate kshA PCR primers KshA-
Type-F and KshAType-R (Fig. 2; Table 1) were developed to
screen the kshA1 gene deletion mutant strain RG2 for the
presence of kshA gene homologues. The degenerate primers
were designed on the conserved Rieske [2Fe-2S] domain (99
CPFHDWRWG 107 in KshA1) and the nonheme Fe(II) bind-
ing domain (191 DMAHFFYVH 199 in KshA1) using an
alignment of amino acid sequences of KshA1 and putative
actinomycetal orthologues identified by BLAST in data-
bases (http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi)
(24). PCR experiments with these degenerate primers on total
DNA of strain RG2 resulted in a PCR product of the expected
size (0.3 kb). Nucleotide sequence analysis revealed that part
of a kshA homologue had been cloned that was very similar,
but not identical, to that of kshA1; thus, it was designated
kshA2.
Cloning of kshA2 from Rhodococcus erythropolis SQ1. A
genomic library of R. erythropolis strain RG1 (24) was screened
using the degenerate kshA1 PCR primers, and a clone was
isolated, designated pAR1, that contained the kshA2 gene.
Nucleotide sequencing of this clone revealed that the 3-end
part of the kshA2 gene was not present. The genomic library
was thus screened again by PCR using newly designed kshA2
primers KshA2-F and KshA2-R (Table 1) for an additional
clone containing the 3 end of kshA2. Primers KshA2-F and
KshA2-R were designed on the conserved Rieske [2Fe-2S]
domain (LDAYCRH) and the conserved VLINCHYP motif,
respectively. The nucleotide sequence of the complete kshA2
gene (1,167 nucleotides) was determined from sequencing data
of both kshA2-positive clones.
kshA2 (GC content, 58.2%) encodes a protein (KshA2) of
388 amino acids with a calculated molecular mass of 44 kDa.
KshA2 displays highest overall amino acid sequence identity
to Ro05811 of R. jostii RHA1 (11) (63%). High sequence
identity was also found with KshA1 of R. erythropolis SQ1
(60%). The typical class IA terminal oxygenase Rieske type
[2Fe-2S]R domain (C-X-H-X16-C-X2-H) and the mononu-
clear, nonheme Fe(II) binding motif (D/E-X3-D-X2-H-X4-
H), previously identified in KshA1, were also fully conserved
in KshA2.
Transcriptional analysis revealed that kshA2 is steroid in-
ducible. To verify that kshA2 is involved in steroid catabolism
in R. erythropolis strain SQ1, we performed transcriptional
analysis of kshA2 gene expression by RT-PCR. Significant
amounts of kshA2 RNA transcript were observed in cell cul-
tures of parent strain SQ1 grown in complex medium (LBP)
following AD induction (Fig. 4, lane 2). A very low level of
kshA2 RNA transcript was found in control cell cultures with-
out steroid induction (Fig. 4, lane 1). Thus, kshA2 is steroid
inducible and most likely part of the steroid catabolic pathway.
The kshA1 mutant strain RG2 is unable to grow on AD, ap-
parently failing to use KshA2. KshA2 induction thus may re-
quire further conversion of AD, which is possible in wild-type
strain SQ1 but not in strain RG2.
kshA2 encodes KSH activity and is under transcriptional
control. To determine whether kshA2 can functionally comple-
ment the AD growth-negative phenotype of kshA1 mutant
strain RG2 and hence whether it encodes KSH activity, we
forced expression of kshA2 in strain RG2 by putting kshA2
under the control of the promoter of kstD (22). The kstD
FIG. 3. Derivatives of Rhodococcus expression vector pRESX used in this study for expression of kshA2 (pKSH312) and kshA2 and kshB
(pKSH313) in gene deletion mutants of R. erythropolis SQ1. The pRESX vector contains the kstD1 promoter region providing constitutive gene
expression in R. erythropolis (unpublished data).
FIG. 4. Transcriptional analysis of kshA2, kstD1 (positive control
for AD induction), and 16S rRNA (control) by RT-PCR using total
RNA isolated from noninduced cultures (lane 1) and AD-induced
cultures of parent strain R. erythropolis SQ1 (lane 2). PCR primers
used are RT-KSHA2-F and RT-KSHA2-R for kshA2, RT-KSTD1-F
and RT-KSTD1-R for kstD1, and 16SRNA-RHODO-F and 16SRNA-
RHODO-R for 16S rRNA (Table 1).
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promoter region, without its regulatory gene kstR, was cloned
into pRESQ (24), yielding plasmid pRESX, and resulting in
constitutive gene expression in R. erythropolis (Fig. 3) (unpub-
lished data). The kshA2 gene was cloned into pRESX under
the control of the kstD promoter, and the resulting plasmid
pKSH312 (Fig. 3) was introduced into mutant strain RG2 by
electrotransformation. Functional complementation of the AD
growth-negative phenotype of strain RG2 harboring pKSH312
was observed (Fig. 5), confirming that kshA2 indeed is a kshA1
homologue, encoding a second terminal oxygenase component
(KshA2) with KSH activity in R. erythropolis strain SQ1. The
results furthermore suggest that the kshA2 promoter is under
transcriptional control, since the kshA2 gene’s own promoter
does not promote growth of RG2 on AD (Fig. 5) although the
presence of AD induces kshA2 expression in strain SQ1 (Fig.
4). Additionally, plasmid pKSH312 was introduced into the
kshA1 kstD1 kstD2 triple gene deletion mutant strain RG9,
unable to form 9OHAD from AD (24). Introduction of a copy
of the kshA2 gene under the control of the kstD1 promoter
restored the capability of strain RG9 to produce 9OHAD
during AD biotransformation, as determined by high-pressure
liquid chromatography/UV analysis. Thus, KshA2 displays AD
9-hydroxylase activity.
The kshA2 promoter is induced by 9OHAD. Paradoxically,
the kshA1 mutant R. erythropolis strain RG2 cannot grow on
AD as the sole carbon and energy source (24) despite the
presence of a kshA2 homologue, encoding an enzyme with AD
9-hydroxylase activity. To determine whether the kshA2 gene
is actually transcribed in strain RG2, we checked kshA2 pro-
moter activity by fusing the kshA2 promoter region to the bla
gene, encoding -lactamase activity. To the best of our knowl-
edge, this is the first report on the use of E. coli -lactamase as
a convenient transcription reporter protein in Rhodococcus.
Noninduced cell cultures of parent strain SQ1 and kshA1
mutant strain RG2 showed very low kshA2 promoter activities
(Fig. 6). Upon induction with AD, ADD, or 9OHAD, highly
elevated levels of kshA2 promoter activity were observed with
strain SQ1. Cell cultures of RG2, however, showed a different
induction pattern. The kshA2 promoter activity in cell cultures
of RG2 induced with 9OHAD was comparable to the levels
found in parent strain SQ1 (Fig. 6), whereas RG2 cultures
induced with AD or ADD showed greatly reduced (
20%)
kshA2 promoter activities compared to those of parent strain
SQ1. These results indicate that neither AD nor ADD, but
9OHAD (or a metabolite thereof), is the actual inducer of
kshA2 expression. These observations also provide a plausible
explanation for the AD/ADD growth-negative phenotype of
the RG2 mutant. In strain RG2, kshA2 expression is not suf-
ficiently induced in the presence of AD to allow growth on this
steroid substrate as a sole carbon and energy source.
Gene deletion of kshA2 does not affect growth on 9OHAD,
cholesterol, or cholic acid. Since kshA2 is induced predomi-
nantly by 9OHAD, we considered the possibility that the AD
9-hydroxylase activity observed for KshA2 is not its main
enzymatic activity. Instead, KshA2 might have an essential
function in the further degradation of 9OHAD. To test this
hypothesis, kshA2 gene deletion mutant strain RG23 and
kshA1 kshA2 double gene deletion mutant strain RG24 were
constructed from parent SQ1 and kshA1 mutant strain RG2,
respectively. Growth of RG23 or RG24 in 9OHAD mineral
medium was comparable to that of RG2 and parent strain
SQ1, indicating that kshA2 is not essential for further 9OHAD
degradation. Also growth of RG23 and RG24 on alternative
classes of steroid substrates, i.e., sterols (cholesterol) and bile
acids (cholic acid), as sole carbon and energy sources was
similar to that of the parent strain. kshA2 therefore is not
essential for the degradation of either of these steroid sub-
strates. Growth of RG24 on cholic acid mineral medium was
impaired compared to that of SQ1, but this was shown to be
solely due to the inactivation of kshA1, since RG2 was im-
paired in growth on cholic acid to the same extent.
Functional complementation of RG2 by kshA2 is dependent
on the presence of kshB. KshA2 expectedly is part of a class IA
two-component enzyme system, raising the question whether
KshA2 could form an active enzyme complex with the previ-
ously identified KshB class IA oxygenase-reductase component
(24) as part of a putative KshA2/KshB two-component en-
FIG. 5. Functional complementation of growth of kshA1 mutant R.
erythropolis RG2 by kshA2 in AD mineral medium (average of
duplicates). Growth curves represent parent strain (diamonds),
kshA1 mutant strain RG2 (crosses), and RG2 harboring kshA2 on
expression plasmid pKSH312 (Fig. 3) (triangles). OD600, optical
density at 600 nm.
FIG. 6. Promoter activity of kshA2 following induction by AD,
ADD, or 9OHAD in parent strain SQ (open bars) and kshA1 mutant
strain RG2 (solid bars), using leaderless -lactamase as a reporter
protein (14, 20).
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zyme. Alternatively, KshA2 may form a two-component en-
zyme system with a different, yet unknown, oxygenase-reduc-
tase component.
Functional complementation of growth of kshA1 mutant
RG2, kshB mutant RG4 (24), and kshA1 kshB double mutant
RG27 on ADD mineral agar plates by the kshA2 gene was
therefore tested. Following the introduction of kshA2 expres-
sion plasmid pKSH312 (Fig. 3) into these strains, functional
complementation of growth on ADD was observed only with
mutant strain RG2, harboring an intact copy of the kshB gene.
KshA2 thus indeed is active in the presence of the KshB com-
ponent, indicating that KshB can function as an oxygenase-
reductase for both KshA1 and KshA2 (Fig. 1). The formation
of an active KshA2/KshB two-component enzyme system was
furthermore supported by the observed functional comple-
mentation of growth on ADD mineral agar medium of strain
RG27 harboring pKSH313, a pRESX derivative carrying both
kshA2 and kshB (Fig. 3).
Identification of a third homologue, kshA3, in a kshA1 kshA2
double mutant. In order to determine whether strain SQ1
contains more kshA homologues in addition to kshA1 and
kshA2, PCR was performed on total DNA of the kshA1 kshA2
mutant strain RG24 using the degenerate kshA PCR primers
(KshAType-F and KshAType-R, Table 1). Indeed, a PCR
product of the expected size (0.3 kb) was obtained and nucleo-
tide sequence analysis revealed that an additional kshA homo-
logue had been amplified, designated kshA3. We additionally
succeeded in obtaining a 0.6-kb PCR product of kshA3 from
RG24 using PCR primers originally developed for kshA2
(KSHA2-F and KSHA2-R, Table 1). The nucleotide sequences
of the 0.3-kb and 0.6-kb PCR products were 100% identical in
the overlapping region, indicating that both PCR products
originated from the same gene (kshA3). The deduced amino
acid sequence of the partial KshA3 protein encoded by the
0.6-kb PCR product (199 amino acids) displayed the highest
similarity with Ro04538 (89% identity over 199-amino-acid
stretch) from R. jostii RHA1 (11). KshA3 is also highly similar
to the same stretch of amino acids of KshA1 (69% identity)
and KshA2 (66% identity). R. erythropolis strain SQ1 thus
contains at least three kshA homologues.
DISCUSSION
Two enzymatic activities, i.e., KSTD and KSH, are involved
in the opening of the steroid B-ring during microbial steroid
degradation. In previous work, we have identified one KSH
activity, comprised of KshA1 and KshB, and two KSTD activ-
ities, KSTD1 and KSTD2, in R. erythropolis SQ1 that are in-
volved in the degradation of AD (22, 23, 24, 25). Here, we
report the identification and characterization of a second ter-
minal oxygenase component, KshA2, in R. erythropolis SQ1 as
part of the AD catabolic pathway (Fig. 1).
The kshA2 gene codes for a second terminal oxygenase com-
ponent, KshA2, in R. erythropolis SQ1 with AD 9-hydroxylase
activity. In parent strain SQ1, expression of kshA2 is induced
by AD. However, analysis of induction of kshA2 promoter
activity, using -lactamase as a convenient reporter protein,
showed that 9OHAD serves as a much better inducer than
does AD or ADD. Thus, 9OHAD, or a metabolite thereof, is
the actual inducer of kshA2 expression. The kshA2 promoter
study also provided an explanation for the observation that
kshA1 mutant strain RG2 is unable to grow on AD or ADD,
despite the presence of a functional kshA2 gene. In RG2,
kshA2 is unable to take over the function of kshA1, because
expression of kshA2 is not sufficiently induced in the presence
of AD or ADD and also because 9OHAD is not formed.
kshA2 clearly is under transcriptional control: kshA2 episo-
mally expressed under the control of a constitutive promoter
(kstD1) yielded KSH activity that could restore the growth of
the mutant strain RG2 on AD. Interestingly, kshA2 is preceded
by an open reading frame (ORF2) (Fig. 2), encoding a 238-
amino-acid protein displaying similarity to IclR-type transcrip-
tional regulators (ScanProsite, www.expasy.ch). The ORF2-en-
coded protein contains an IclR-type helix-turn-helix domain
(PS51077) and an IclR-type effector domain (PS51078). The
protein also displays similarity to the IclR-type regulator iden-
tified upstream of the bphC1 gene in Rhodococcus rhodochrous
K37 and KsdR, a putative DNA binding regulatory protein of
ksdD encoding KSTD in Arthrobacter simplex (12, 21). The
bphC1 gene of R. rhodochrous K37 is induced by the steroid
testosterone (21). Based on these similarities, ORF2 might
encode a transcriptional regulator for kshA2 expression. Most
IclR-type transcription regulators are repressors of specific
catabolic genes in the absence of specific substrates, while
excess of a specific effector triggers derepression (Prosite doc-
umentation PDOC00807, www.expasy.ch). If the ORF2-en-
coded protein indeed acts as a repressor of kshA2 expression,
inactivation of ORF2 should restore growth of RG2 on AD.
However, when we performed a gene deletion of ORF2 in R.
erythropolis strain RG2, growth of the resulting double mutant
on AD was not restored (data not shown). Thus, the ORF2-
encoded protein most likely is not a repressor of kshA2
expression.
The terminal oxygenase KshA2 activity is observed only in
the presence of KshB, suggesting that KshA2/KshB constitute
a second KSH enzyme activity (KSH2), in addition to the KSH
activity of KshA1/KshB in R. erythropolis SQ1. KshB has been
classified as a class IA oxygenase-reductase (24). Therefore, we
can classify KshA2 as a class IA terminal oxygenase. Strain
SQ1 most likely contains only one oxygenase-reductase, KshB,
supplying reducing equivalents to multiple terminal oxygen-
ases. This is in agreement with the observed phenotype of kshB
mutant RG4, which is fully blocked in AD and cholesterol
degradation (24), likely due to a lack of supply of reducing
equivalents toward KshA1, KshA2, and additional homo-
logues, e.g., KshA3.
Inactivation of kshA2 did not result in blocked growth on
9OHAD, cholic acid, or cholesterol. The kshA2 gene thus does
not have an essential role in the degradation of either of these
different classes of steroids. Speculatively, KshA2 might play a
role in limiting the metabolic flux through ADD during AD
catabolism. Keeping the intracellular levels of ADD low by
regulating KSTD and KSH activities would be advantageous to
the cell, since ADD is known to have toxic effects (15). Inter-
estingly, ADD biotransformation experiments with R. eryth-
ropolis cell cultures generally result in a temporal accumulation
of AD (data not shown), indicating the presence of 3-ketos-
teroid 1-reductase activity (KSR, Fig. 1). 1-Reductase activ-
ity has also been observed in Mycobacterium sp. strain NRRL
B-3805, and the activity increased significantly upon induction
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of cultures by ADD (7). The above-mentioned data suggest a
preference for steroid catabolism via 9-hydroxylated rather
than 1-desaturated steroid pathway intermediates. Degrada-
tion of AD via the 9OHAD intermediate and not via the
moderately toxic intermediate ADD would be beneficial to the
cell, necessitating the activation of an additional KSH activity,
i.e., KshA2 (Fig. 1).
A third kshA gene (kshA3) was successfully identified by
PCR in kshA1 kshA2 mutant RG24 by using the developed
degenerate primers for kshA1, indicating that these are suit-
able PCR primers for the amplification of kshA gene homo-
logues. These primers can thus be used to screen for, and
clone, additional kshA genes from other interesting (acti-
no)bacteria. The KshA3 protein sequence displayed highest
identity with Ro04538 from R. jostii RHA1. Interestingly, the
ro04538 gene is part of the cholesterol catabolic gene cluster
recently identified in R. jostii RHA1 (27), suggesting that
kshA3 encodes the KSH oxygenase component involved in
cholesterol catabolism in R. erythropolis SQ1.
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